medigraphic.com

2019, Number 2

<< Back Next >>

Rev Fac Med UNAM 2019; 62 (2)

Negative Epstein-Barr mononucleosis. Little-recognized variation in a frequent disease

Rubalcava LLF, Tello CJK

Language: Spanish
References: 28
Page: 31-38
PDF size: 222.52 Kb.


ABSTRACT

We present the case of a young patient, immunocompetent and without risk factors, with a condition compatible with mononucleosis syndrome (cervical lymphadenopathy, fever, malaise), which was characterized by persistent symptoms, despite multiple antibiotic treatments. During its approach infection was ruled out due to the most common causes of fever and Epstein-Barr infection, for which serological tests were performed where it was corroborated an etiology that is unusual that is presented as infectious mononucleosis. By identifying the infectious agent and because it was associated with haematological alterations, organomegalias and myositis during its evolution, the patient was a candidate for antibiotic treatment, with notable improvement when he started it, which led to his total recovery.


REFERENCES

  1. Branson BM, Stekler JD. Detection of acute HIV infection: We can’t close the window. J Infect Dis 2012;205(4):521-4.

  2. Malm K, Von-Sydow M, Andersson S. Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples. Transfus Med. 2009;19(2)78-88.

  3. Jones JL, Kruszron-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999- 2004, decline from the prior decade. Am J Trop Med Hyg. 2007;77(3):405-10.

  4. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status in Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol. 2009;39(12):1385-94.

  5. Hernández-Cortazar I, Acosta-Viana KY, Ortega-Pacheco A, Guzman-Marin E, Aguilar-Caballero AJ Jimenez-Coello M. Toxoplasmosis in Mexico: epidemiological situation in humans and animals. Rev Inst Med Trop Sao Paulo. 2015;57(2):93-103.

  6. Carrada-Bravo T. Toxoplasmosis: parasitosis reemergente del nuevo milenio. Rev Lationoamer Patol Clin. 2005;52(3):151-62.

  7. Robert-Gagneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264-96.

  8. Ryning FW, McLeod R, Maddox JC, Remington JS. Probable transmission of Toxoplasma gondii by organ transplantation. Ann Intern Med. 1979;90(1):47-9.

  9. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12- 13):1217-58.

  10. Holland GN. Ocular toxoplasmosis: a global reassessment. Part 1: epidemiology and course of disease. 2003;136(6):973-88.

  11. McCabe RE, Brooks RG, Dorfman RF, Remington JS. Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy. Rev Infect Dis. 1987;9(4):754-74.

  12. Luzuriaga K, Sullivan JL. Infectious Mononucleosis. NEJM. 2010;27;362(21):1993-2000.

  13. Evans AS. Infectious mononucleosis and related syndromes. Am J Med Sci. 1978;276(3):325-39.

  14. Vouloumanou EK, Rafailidis PI, Falagas ME. Current diagnosis and management of infectious mononucleosis. Curr Opin Hematol. 2012;19(1):14-20.

  15. Zhang L, Zhou P, Meng Z, Pang C, Gong L, Zhang Q, et al. Infectious mononucleosis and hepatic function. Exp Ther Med. 2018;15(3):2901-9.

  16. Tian AL, Li GX, Elsheikha HM, Gardner DS, Zhang XY, Dong W, et al. Seroepidemiology of Toxoplasma gondii infection in patients with liver disease in eastern China. Epidemiol Infect. 2017;145(11):2296-302.

  17. Abd El-Rehim El-Henawy A, Abdel-Razik A, Zakaria S, Elhammady D, Saudy N, Azab MS. Is Toxoplasmosis a potential risk factor for liver cirrhosis. Asian Pac J Trop Med. 2015. 8(10):784-91.

  18. Alvarado-Esquivel C, Torres-Berumen JL, Estrada-Martínez S, Liesenfeld O, Mercado-Suarez MF. Toxoplasma gondii infection and liver disease: a case-control study in a northern Mexican population. Parasit Vectors. 2011;13;4;75.

  19. Noble J. Infectious mononucleosis. Textbook of primary care medicine. 3er ed. New York, NY: Mosby; 2001.

  20. Dommerby H, Stanferup SE, Stangerup M, Hancke S. Hepatosplenomegaly in infectious mononucleosis, assessed by ultrasound scanning. J Laryngol Otol. 1986;100:573-9.

  21. Rea TD, Russo JE, Katon W, Ashley RL, Buchwald DS. Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. J Am Board Fam Pract. 2001;14(4):234-42.

  22. Glatman-Zaretsky A, Silver JS, Siwicki M, Durham A, Ware CF, Hunter CA. Infection with Toxoplasma gondii alters lymphotoxin expression associated with changed in splenic architecture. Infect Immun. 2012;80(10):3602-10.

  23. Flament-Durand J, Coers C, Waelbroeck C. Toxoplasmic encephalitis and myositis during treatment with immunodepressive drugs. Acta Clin Belg. 1967;22(1):44-54.

  24. Greenlee JE, Johnson WD, Campa JF, Adelman LS, Sande MA. Adult toxoplasmosis presenting as polymyositis and cerebellar ataxia. Ann Intern Med. 1975;82(3):367-71.

  25. Gherardi R, Baudrimont M, Lionnet F, Salord JM, Duvivier C, Michon C, et al. Skeletal muscle toxoplasmosis in patients with acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol. 1992;32(4):535-42.

  26. Matsubara S, Takamori M, Adachi H, Kida H. Acute toxoplasma myositis: an immunohistochemical and ultrastructural study. Acta Neuropathol. 1990;81(2):223-7.

  27. Centers for Disease Prevention and Control. Actualizado diciembre 18, 2017. Toxoplasma gondii. [Consultado: octubre 2, 2018]. Disponible en: https://www.cdc.gov/dpdx/ toxoplasmosis/index.html.

  28. Alavi SM, Alavi L. Treatment of toxoplamic lymphadenitis with co-trimoxazole: double-blind randomized trial. Int J Infect Dis. 2010;14:3e67-9.




2020     |     www.medigraphic.com